Correlation Between Finch Therapeutics and NewGenIvf Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Finch Therapeutics and NewGenIvf Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Finch Therapeutics and NewGenIvf Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Finch Therapeutics Group and NewGenIvf Group Limited, you can compare the effects of market volatilities on Finch Therapeutics and NewGenIvf Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Finch Therapeutics with a short position of NewGenIvf Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Finch Therapeutics and NewGenIvf Group.

Diversification Opportunities for Finch Therapeutics and NewGenIvf Group

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Finch and NewGenIvf is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Finch Therapeutics Group and NewGenIvf Group Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewGenIvf Group and Finch Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Finch Therapeutics Group are associated (or correlated) with NewGenIvf Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewGenIvf Group has no effect on the direction of Finch Therapeutics i.e., Finch Therapeutics and NewGenIvf Group go up and down completely randomly.

Pair Corralation between Finch Therapeutics and NewGenIvf Group

If you would invest  4.88  in NewGenIvf Group Limited on September 30, 2024 and sell it today you would lose (0.39) from holding NewGenIvf Group Limited or give up 7.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy0.95%
ValuesDaily Returns

Finch Therapeutics Group  vs.  NewGenIvf Group Limited

 Performance 
       Timeline  
Finch Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Finch Therapeutics Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, Finch Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.
NewGenIvf Group 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in NewGenIvf Group Limited are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating technical and fundamental indicators, NewGenIvf Group showed solid returns over the last few months and may actually be approaching a breakup point.

Finch Therapeutics and NewGenIvf Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Finch Therapeutics and NewGenIvf Group

The main advantage of trading using opposite Finch Therapeutics and NewGenIvf Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Finch Therapeutics position performs unexpectedly, NewGenIvf Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewGenIvf Group will offset losses from the drop in NewGenIvf Group's long position.
The idea behind Finch Therapeutics Group and NewGenIvf Group Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data